Alzheimer's disease Trials in Paris, France
Conditions / Alzheimer's disease / Paris, France
Research into Alzheimer's disease spans multiple therapeutic approaches and trial phases.
59 total trials for this combination
Showing top 10 of 59 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04520412 | A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease | SUSPENDED | PHASE3 |
| NCT00667810 | Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients | TERMINATED | PHASE3 |
| NCT03444870 | Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) | TERMINATED | PHASE3 |
| NCT04619420 | A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT00676143 | Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients | TERMINATED | PHASE3 |
| NCT07011745 | A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2) | RECRUITING | — |
| NCT04374253 | A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD) | TERMINATED | PHASE3 |
| NCT06937229 | A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) | RECRUITING | — |
| NCT05531526 | Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00506415 | Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline | COMPLETED | PHASE3 |